Gene Information
Gene Name
|
ERBB4 |
Gene ID
|
2066
|
Gene Full Name
|
erb-b2 receptor tyrosine kinase 4 |
Gene Alias
|
HER4; ALS19; p180erbB4 |
Transcripts
|
ENSG00000178568
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
|
Membrane Info
|
Predicted membrane proteins |
HPA Protein Class Info
|
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters |
Gene Function
|
Suppressor gene &
Oncogene
|
Uniport_ID
|
Q15303
|
HGNC ID
|
HGNC:3432
|
VEGA ID
|
OTTHUMG00000133012
|
OMIM ID
|
600543 |
String ID
|
9606.ENSP00000342235
|
Drugbank ID
|
BE0004772
|
Drug (Cytoscape Annotation)
|
Lapatinib Ditosylate;Gefitinib;Dasatinib;AfatinibDimaleate;Bosutinib;Erlotinib Hydrochloride;Vandetanib |
PharmGKB ID
|
PA27847
|
FDA Approved Drug
|
Dacomitinib |
Target gene [ERBB4] related to VISs
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of ERBB4 expression and immune infiltrating cell level correlation result in HBV+ samples
|
ERBB4 expression: Low -> High
|
|
|
|
|